While gurus hold positions in these companies, the stock price sand returns continue to fall. These are the worst-performing stocks over the last three months with a long-term presence in more than four gurus’ portfolios.
Biocryst Pharmaceuticals Inc. (BCRX, Financial) had a negative performance of 15.4% over the last six months. Three mutual funds hold the stock with a total weight of 0.05% on their portfolios.
The biotechnology company has a market cap of $471.27 million, and the stock is trading with a price-sales (P/S) ratio of 14.03. The current price of $5.86 is 36.65% below its 52-week high and 107.07% above its 52-week low. Over the last 10 years, it returned a gain of 96%.
Over the last five years, the company reported a 2.1% decrease in revenue and a 8.% decline in earnings per share (EPS).
The return on equity (ROE) of -272.79% and return on assets (ROA) of -46.91% are underperforming 91% of other companies in the Global Biotechnology industry.
With 4.61% of outstanding shares,Ă‚ D.E. Shaw & Co. LPĂ‚ is the largest investor among the gurus, followed by John Paulson (Trades, Portfolio) with 0.44%, Jim Simons (Trades, Portfolio) with 0.27%, Chuck Royce (Trades, Portfolio) with 0.18% and Joel Greenblatt (Trades, Portfolio) with 0.16%.
Carlisle Companies Inc.Ă‚ (CSL, Financial) had a negative performance of 10.7% over the last six months. Three mutual funds hold the stock with a total weight of 0.25% on their portfolios.
The construction materials manufacturer has a market cap of $6.28 billion. The stock is trading with a P/S ratio of 1.67. The current price of $97.14 of 16.55% is below its 52-week high and 3.93% above its 52-week low. Over the last 10 years, it returned a loss of 8%.
Over the last five years, Carlisle reported a gain of 6.90% for its revenue and 7.90% for EPS.
The ROE of 9.81% and ROA of 6.03% are outperforming 52% of other companies in the Global Rubber and Plastics industry.
The largest shareholder among the gurus is Simons with 0.82% of outstanding shares, followed by Columbia Wanger (Trades, Portfolio) with 0.69%, Greenblatt with 0.18%, Royce with 0.1%, Caxton Associates (Trades, Portfolio) with 0.08%, Jeremy Grantham (Trades, Portfolio) with 0.05% and Paul Tudor Jones (Trades, Portfolio) with 0.01%.
WEX Inc.Ă‚ (WEX, Financial) had a negative performance of 6.8% over the last six months. Three mutual funds hold the stock with a total weight of 3.06% on their portfolios.
The payment processing company has a market cap of $4.54 billion, and the stock is trading with a P/S ratio of 4.04. The current price of $105.94 is 13.81% below its 52-week high and 22.15% above its 52-week low. Over the last 10 years, it returned a gain of 20%.
Over the last five years, Wex reported an 11.8% increase in revenue, but a 10.1% decrease for EPS.
While the ROE of 4.93% is outperforming the sector, ROA of 1.24% is underperforming 68% of other companies in the Global Business Services industry.
With 2.14% of outstanding shares, Steven Cohen (Trades, Portfolio)  is the largest investor among the gurus, followed by Mariko Gordon (Trades, Portfolio) with 1.13%, Ron Baron (Trades, Portfolio) with 1.05%, Keeley Asset Management Corp (Trades, Portfolio) with 0.55%, Simons with 0.33% and Greenblatt with 0.21%.
Plains All American Pipeline LPĂ‚ (PAA, Financial) had a negative performance of 16.9% over the last six months. Four mutual funds hold the stock with a total weight of 3.25% on their portfolios.
The midstream oil and gas company has a market cap of $19.12 billion, and the stock is trading with a P/S ratio of 0.62. The current price of $26.38 is 22.30% below its 52-week high and 13.66% above its 52-week low. Over the last 10 years, it returned a loss of 3%.
Over the last five years, the company reported a loss of 18% for revenue and 29.50% for EPS.
The current ROE of 6.20% is underperforming the sector, while ROA of 4.32% is outperforming 53% of other companies in the Global Oil and Gas Midstream industry.
The largest shareholder among the gurus is Michael Price (Trades, Portfolio) with 0.06% of outstanding shares, followed by Simons with 0.03%, T Boone Pickens (Trades, Portfolio) with 0.02% and First Eagle Investment (Trades, Portfolio) with 0.01%.
United Therapeutics Corp. (UTHR, Financial) had a negative performance of 8.3% over the last six months. Three mutual funds hold the stock with a total weight of 0.49% on their portfolios.
The biotechnology company has a market cap of $6.03 billion, and the stock is trading with a P/S ratio of 3.88. The current price of $133.86 is 21.21% below its 52-week high and 25.97% above its 52-week low. Over the last 10 years, it returned a gain of 22%.
Over the last five years, the company reported a gain of 21% for its revenue and 33.8% for its EPS.
The ROE of 35.41% and ROA of 28.43% are outperforming 98% of other companies in the Global Biotechnology industry.
With 1.12% of outstanding shares, Simons is the largest investor among the gurus, followed by Greenblatt with 0.46%, Ray Dalio (Trades, Portfolio) with 0.13%, John Hussman (Trades, Portfolio) with 0.06%, Lee Ainslie (Trades, Portfolio) with 0.04%, Jones with 0.01% and Ken Fisher (Trades, Portfolio) with 0.01%.
Gigamon Inc. (GIMO, Financial) had a negative performance of 11.6% over the last six months. Three mutual funds hold the stock with a total weight of 0.89% on their portfolios.
The communication equipment company has a market cap of $1.43 billion, and the stock is trading with a P/S ratio of 4.65. The current price of $38.85 is 36.57% below its 52-week high and 36.32% above its 52-week low. Over the last 10 years, it returned a gain of 3%.
Over the last five years, Gigamon reported 11.7% revenue growth. The ROE of 18.78% and ROA of 12.42% are outperforming 85% of other companies in the Global Communication Equipment industry.
The largest shareholder among the gurus is Elliott Associates LP with 4.87% of outstanding shares, followed by Leon Cooperman (Trades, Portfolio) with 0.98%, George Soros (Trades, Portfolio) with 0.92%, Greenblatt with 0.17%, Hussman with 0.14%, Jones with 0.12% and Royce with 0.07%.
Papa John's International Inc.Ă‚ (PZZA, Financial) had a negative performance of 16.6% over the last three months. Despite this, three mutual funds hold the stock with a total weight of 0.11% on their portfolios.
The pizza chain has a market cap of $2.64 billion, and the stock is trading with a P/S ratio of 1.57. The current price of $71.87 is 20.58% below its 52-week high and 7.30% above its 52-week low. Over the last 10 years, it returned a gain of 6%.
Over the last five years, Papa John's reported a 13.7% increase in revenue and an 18.4% increase in EPS.
The ROA of 20.96% and return on capital (ROC) of 73.27% are outperforming 85% of other companies in the Global Restaurants industry.
With 2.11% of outstanding shares, Columbia Wanger is the largest investor among the gurus, followed by Simons with 2.1%, Cohen with 0.29%, Soros with 0.02%, Murray Stahl (Trades, Portfolio) with 0.01%, Caxton Associates with 0.01% and Grantham with 0.01%.
Disclosure: I do not own any shares of any stocks mentioned in this article.
